Australia recommends OTC switch for triptans

7 February 2020 - Deborah Wilkes


Australia's Advisory Committee on Medicines Scheduling (ACMS) has recommended two triptans – sumatriptan and zolmitriptan – should be switched from prescription to non-prescription status for treating migraine.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: